<DOC>
	<DOCNO>NCT02855658</DOCNO>
	<brief_summary>To evaluate modulation immunity-related gene expression Sjögren 's syndrome Chinese herbal medicine ( SS-1 ) treatment .</brief_summary>
	<brief_title>Modulation Immunity-related Gene Expression Under Chinese Herbal Formula SS-1 Treatment Sjögren 's Syndrome</brief_title>
	<detailed_description>Objective : To evaluate modulation immunity-related gene expression Sjögren 's syndrome Chinese herbal medicine ( SS-1 ) treatment . Method : The evidence regulation oxidative-related cytokine antioxidant capacity could provide previous randomize , double-blinded , placebo-controlled , cross-over design , two-center clinical trial evaluate effect Chinese herbal medicine ( SS-1 ) Sjögren 's syndrome patient . However , clinical trail could find modulation immunity-related gene expression SS-1 treatment , set healthy control group SS-1 comparison . This study want establish healthy control group evaluate normal range oxidative stress cytokine , work could use compare 72 SS-1 subject previous study . And This study also want analyze 770 immunity-related gene expression Sjögren 's syndrome SS-1 treatment : ( 1 ) The best 20 ( least ) efficacy SJS subject evaluate SS-1 treatment . ( 2 ) The 10 ( least ) healthy control subject . The finding could provide evidence modulation immunity-related gene expression clinical manifestation , oxidative stress cytokine Sjögren 's syndrome patient . Expected Results : 1 . Establish normal range oxidative stress cytokine healthy control group . 2 . To evaluate regulatory effect oxidative stress cytokine secretion SS-1 group healthy control group . 3 . To evaluate immunity-related gene expression Sjögren 's syndrome SS-1 treatment . 4 . To evaluate immunity-related gene expression among best efficacy SJS subject healthy control subject . 5 . To evaluate immunity-related gene expression characteristic TCM tongue diagnosis . 6 . To analyze correlation among clinical manifestation , Sjögren 's syndrome -related clinical questionnaire immunity-related gene expression .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Sjogren 's Syndrome</mesh_term>
	<criteria>Primary Secondary Sjögren 's syndrome patient Age 20 75 year old , male female patient Fit criterion 2002 year AmericanEuropean classification If subject take Cyclosporine , Cevimeline , Pilocarpine , Rituximab biological agent enter study , subject need stop drug one month If subject take GanLuYin , Sang JuYin XuefuZhuyuDecoction enter study , subject need stop drug one month Secondary Sjögren 's syndrome patient : Stable treatment : Steroid ( ≦10mg/d ) fix hydroxychloroquine dose 3 month enrol No abnormal change immunology , liver , kidney , blood function No major life threaten condition Alcohol abuse , DM ( Glucose PC &gt; 200mg/dL ) major life threaten condition Pregnancy breast feed Abnormal liver kidney function Forbid steroid pulse therapy 3 month enrol study , forbid Chinese herbal medicine except SS1</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Sjögren 's syndrome</keyword>
	<keyword>Gan-Lu-Yin</keyword>
	<keyword>Sang-Ju-Yin</keyword>
	<keyword>Xuefu-Zhuyu-Decoction</keyword>
	<keyword>Oxidative stress</keyword>
	<keyword>Immune regulation</keyword>
	<keyword>Gene modulation</keyword>
	<keyword>SS-1</keyword>
</DOC>